Dunhill Financial’s Clover Health Investments CLOV Stock Holding History

Dunhill Financial’s Portfolio CLOV Stock Details CLOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-10	Closed	-$17	–	1675
2026 Q1	$17	Buy	+10	New	+$22	﹤0.01%	1786

Other funds holding CLOV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Dunhill Financial's CLOV Position: Q2 2026 in Review

Dunhill Financial sold out of Clover Health Investments (CLOV) in Q2 2026, closing a stake of 10 shares — an estimated $17 sold.

Dunhill Financial first reported a position in CLOV in Q1 2026 and held it in 1 quarter. The position peaked at $17 in Q1 2026. 227 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

Dunhill Financial reported no remaining Clover Health Investments position as of Q2 2026 after selling out during the quarter.
Dunhill Financial sold 10 Clover Health Investments shares in Q2 2026, an estimated $17.
Dunhill Financial first reported a position in Clover Health Investments in Q1 2026 and held it in 1 quarter.
Dunhill Financial's Clover Health Investments position peaked at $17 in Q1 2026.
227 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on Dunhill Financial's 13F filing for Q2 2026, filed 7 Aug 2026.